News

Clinical Advisor19h

Cardiovascular Benefit Seen With Tirzepatide in Head-to-Head Trial

SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.

Eli Lilly’s weight loss drug most effective at preventing heart attacks and strokes: What new study means for Mounjaro users

Trial shows that risk of a major adverse cardiovascular event is eight per cent lower in people on new therapy ...